Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Determination of the Glycemic Index and the Insulinemic Index of a Sweetener Syrup

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2008 by Routin SA.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Routin SA
ClinicalTrials.gov Identifier:
NCT00717912
First received: July 16, 2008
Last updated: July 17, 2008
Last verified: July 2008

July 16, 2008
July 17, 2008
July 2008
September 2008   (final data collection date for primary outcome measure)
The specific measure that will be use to determine the glycemic responses is the change in blood sugar levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate [ Time Frame: 3 weeks ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00717912 on ClinicalTrials.gov Archive Site
The specific measure that will be use to determine the insulinemic responses is the change in blood insulin levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate [ Time Frame: 3 weeks ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Determination of the Glycemic Index and the Insulinemic Index of a Sweetener Syrup
Determination of the Glycemic Index and the Insulinemic Index of a Sweetener

The purpose of the study is to determine the glycemic index and the insulinemic index of a sweetener syrup

Glycemic index is a measure of how carbohydrate-containing foods affect blood glucose levels. All foods that contain carbohydrates, such as starchy vegetables (potatoes, corn), desserts, fruits, bread, pasta, and rice, can be tested for how they affect blood sugar levels after being eaten. Glycemic index is assessed by having one or more people eat a specific amount of a single food (usually 50 grams of digestible carbohydrate) and then measuring the change in blood sugar levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate, such as white bread or glucose. The average change in blood sugar levels over a set period of time relative to the levels after consumption of the control food, usually white bread or glucose, is the food's glycemic index.

Insulinemic index is measure with the same methodology.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science
Healthy Volunteers
  • Other: experimental sweetener syrup 1
    3 glucose and insulin responses with experimental sweetener syrup 1 : 50 grams of digestible carbohydrate plus fiber
    Other Name: ROUTIN sweetener syrup
  • Other: classical sugar syrup
    3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate
    Other Name: ROUTIN classical sugar syrup
  • Other: experimental sweetener syrup 2
    1 glucose and insulin responses with experimental sweetener syrup 2 : 50 grams of digestible carbohydrate plus fiber
    Other Name: TEISSEIRE sweetener syrup
  • Experimental: 1
    Experimental sweetener syrup 1
    Intervention: Other: experimental sweetener syrup 1
  • Active Comparator: 2
    Classical sugar syrup
    Intervention: Other: classical sugar syrup
  • Active Comparator: 3
    Experimental sweetener syrup 2
    Intervention: Other: experimental sweetener syrup 2
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
6
September 2008
September 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age 18-50 years
  • male
  • healthy volunteers
  • BMI above 25 kg/m²

Exclusion Criteria:

  • no medical history of hypercholesterolemia, high pressure blood, diabetes, sugar intolerance
  • food allergy
  • kidney deficiency
  • liver troubles
  • gastro-intestinal troubles
  • drugs which impair sugar and lipid metabolism
Male
18 Years to 50 Years
Yes
Contact: Jean-Marc Cazaubiel, Doctor 02 40 20 57 99 frederic.valenti@biofortis.fr
France
 
NCT00717912
SIRODEX 9708
Yes
M Jean Marc Cazaubiel, BIOFORTIS
Routin SA
Not Provided
Principal Investigator: Jean-Marc Cazaubiel, Doctor BioFortis
Routin SA
July 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP